Group One Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-31,600
Closed -$94K 5195
2016
Q3
$94K Sell
31,600
-14,500
-31% -$25.1K ﹤0.01% 2963
2016
Q2
$69K Buy
46,100
+40,100
+668% +$91.7K ﹤0.01% 3108
2016
Q1
$22K Sell
6,000
-31,500
-84% -$195K ﹤0.01% 3705
2015
Q4
$379K Sell
37,500
-50,400
-57% -$607K ﹤0.01% 2033
2015
Q3
$1.2M Buy
87,900
+44,100
+101% +$785K 0.02% 1112
2015
Q2
$831K Sell
43,800
-91,700
-68% -$1.98M 0.01% 1366
2015
Q1
$3.55M Buy
135,500
+2,200
+2% +$56K 0.06% 372
2014
Q4
$2.79M Sell
133,300
-26,200
-16% -$660K 0.04% 481
2014
Q3
$5.32M Buy
159,500
+9,100
+6% +$282K 0.08% 271
2014
Q2
$4.83M Buy
150,400
+23,100
+18% +$860K 0.07% 311
2014
Q1
$5.87M Buy
127,300
+82,300
+183% +$4.83M 0.1% 187
2013
Q4
$3.19M Sell
45,000
-198,100
-81% -$15.1M 0.05% 406
2013
Q3
$20.8M Sell
243,100
-64,900
-21% -$5.5M 0.4% 24
2013
Q2
$19.5M Buy
+308,000
New +$16.4M 0.48% 22

Group One Trading's AEGR Position: Q3 2016 in Review

Group One Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 14,362 shares — an estimated $24.9K sold.

Group One Trading first reported a position in AEGR in Q2 2013 and held it in 10 quarters. The position peaked at $4.11M in Q2 2013. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.

  • Group One Trading reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Group One Trading sold 14,362 Aegerion Pharmaceuticals shares in Q3 2016, an estimated $24.9K.
  • Group One Trading first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 10 quarters.
  • Group One Trading's Aegerion Pharmaceuticals position peaked at $4.11M in Q2 2013.
  • 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.

Based on Group One Trading's 13F filing for Q3 2016, filed 14 Nov 2016.